Staff Reporter
The Drug Regulatory Authority of Pakistan (DRAP) has issued licences to the Center for Bioequivalence Studies and Clinical Research (CBSCR), University of Karachi to conduct Bioequivalence and Bioavailability Studies and clinical research project. The CBSCR, which works under Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD, University of Karachi, has also received licence from DRAP to act as a contract research organization (CRO) to conduct clinical trials for national and international market. Prof. Dr. M. Iqbal Choudhary, Director, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi expressed these views while speaking at a meeting held at the CBSCR on Thursday. Prof. Dr. Raza Shah, CBSCR in-charge, was also present on the occasion. Prof. Choudhary congratulated the team of scientists working at the CBSR on this important development.
